Contribution of the prostate limits the usefulness of survivin for the detection of bladder cancer

Journal of Urology

Volumn 174, Issue 5, 2005, Pages 1767-1770

  Davies, Benjamin ^a   Chen, Joseph ^a   Modugno, Francesmary ^b   Weissfeld, Joel ^b   Landsittel, Doug ^b   Dhir, Rajiv ^a   Nelson, Joel ^a   Getzenberg, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Prostate; Prostatectomy; Prostatic neoplasms; Survivin protein, human; Tumor markers, biological

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SURVIVIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 27544503049     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000177070.13987.ce     Document Type: Article

References (10)

1. Smith, S. D., Wheeler, M. A., Plescia, J., Colberg, J. W., Weiss, R. M. and Altieri, D. C.: Urine detection of survivin and diagnosis of bladder cancer. JAMA, 285: 324, 2001
2. Shariat, S. F., Casella, R., Khoddami, S. M., Hernandez, G., Sulser, T., Gasser, T. C. et al: Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol, 171: 626, 2004
3. Hausladen, D. A., Wheeler, M. A., Altieri, D. C., Colberg, J. W. and Weiss, R. M.: Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome. J Urol, 170: 230, 2003
4. Parkin, D. M., Bray, F., Ferlay, J. and Pisani, P.: Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94: 153, 2001
5. Botteman, M. F., Pashos, C. L., Hauser, R. S., Laskin, B. L. and Redaelli, A.: Quality of life aspects of bladder cancer: a review of the literature. Qual Life Res, 12: 675, 2003
6. Botteman, M. F., Pashos, C. L., Redaelli, A., Laskin, B. and Hauser, R.: The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics, 21: 1315, 2003
7. Li, F.: Survivin study: what is the next wave? J Cell Physiol, 197: 8, 2003
8. Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C. et al: Analysis of human transcriptomes. Nat Genet, 23: 387, 1999
9. Shariat, S. F., Lotan, Y., Saboorian, H., Khoddami, S. M., Roehrborn, C. G., Slawin, K. M. et al: Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer, 100: 751, 2004
10. Kishi, H., Igawa, M., Kikuno, N., Yoshino, T., Urakami, S. and Shiina, H.: Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis. J Urol, 171: 1855, 2004